Skip to main content
Caplight Logo









Nervio

Nervio

Private
Tel AvivHealthcare & Life Scienceshttps://www.nervio.ai/

Last Round

Seed

Sep 1, 2025

Total Funding Raised

$6.89M

Company Overview

Nervio is a healthtech company that develops AI-powered intraoperative neuromonitoring solutions to assist surgical teams in preventing nerve injuries during complex surgeries.

Sector

Healthcare & Life Sciences

Verticals

Medical AI, Medical Devices

Business Model

B2B

Customer Profile

Subscription SaaS, Services & Consulting

AI Layer

Application

Keywords

intraoperative neuromonitoringIONMclinical decision supportmedical AIneurosurgery softwaresurgical AIreal-time surgical monitoringAI-powered diagnosticsdigital healthhealth techsurgical workflow automationSaaS healthOR techAI in surgery

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Nervio Comparables

Compare Nervio with similar companies based on industry and business-model similarity.

Nervio comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
READE.ai
84%
NeuroVascular Research & Design
83%
Brainlab
74%

Nervio Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedSep 1, 2025
GrantDec 1, 2024
SeedDec 30, 2020

Key People

Founding team and executive leadership

Omer Zarchi

Chief Scientific Officer, Co-Founder

Founding Team

Rich Vogel

CEO (USA)

Executive Team

Nervio Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 26, 2026

    Monthly visitors increased 167% MoM, reaching 3.2K.

  • Mar 2, 2026

    Monthly visitors increased 108% MoM, reaching 1.8K.

Nervio Filings

Explore SEC and related filing metadata, where available.

Nervio filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Nervio's valuation, stock price, and market status.

Is Nervio a public or private company?

Nervio is a private company.

What is the current stock price of Nervio?

Nervio is a private company with no public stock price. Caplight tracks Nervio's secondary market activity and provides MarketPrice estimates to Caplight users.

How much is Nervio worth (valuation)?

Valuation information for Nervio is not publicly available.

Can I buy Nervio stock?

Nervio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Nervio's last funding round?

Nervio's most recent funding round was Seed on September 1, 2025.

Who are the main investors in Nervio?

Key investors in Nervio include Merchavia Holdings and Investments Ltd, Israel Innovation Authority, eHealth Ventures.

Will Nervio IPO soon?

No public IPO plans have been announced for Nervio.

How can I track Nervio secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Nervio's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersTel Aviv
Employee Range19
Year Founded2020
Last FundingSep 1, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?